Exercise Plus Duloxetine for Knee Osteoarthritis
Key facts
- Who runs it
- University of Maryland, Baltimore
- Where
- Baltimore, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 43 people enrolled
- Started
- 7 Oct 2021
- Ended
- 11 Aug 2025
- Type of study
- Interventional
- Treatments tested
- Aerobic exercise
- Duloxetine
- Record updated
- 29 October 2026
Who can take part
- Age
- 40 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (16)Hide the full registry criteria
Who can take part
- English speaking
- 40 years or older
- Symptomatic knee osteoarthritis fulfilling 1986 American College of Rheumatology criteria
- No plan for surgical knee osteoarthritis intervention within six months of enrollment
- Major depressive disorder satisfying diagnostic criteria according to the DSM-V
- Ability to participate in a supervised aerobic exercise program
Who cannot take part
- Other medications deemed by study team to endanger the health of the participant or unduly confound the results
- Substance abuse disorder or suicidal ideation within the previous year
- Active cancer that is currently undergoing treatment (receiving chemotherapy and/or radiation therapy)
- Cognitive impairment (Mini-Mental State Examination score < 20)
- Past or current bipolar disorder or psychotic symptoms according to the DSM-V
- Not able to participate in a supervised exercise program based on the presence of unstable angina, recent MI (within last 3 months), hemiparetic gait, inability to walk at least 1mph on treadmill safely, poorly controlled hypertension (resting blood pressure > 190/110), peripheral arterial disease with current foot or leg ulcers, or cardiac or pulmonary disease with exercise tolerance NYHA class 3 or higher
- Other conditions deemed by study team to endanger the health of the participant or unduly confound the results
- Already performing aerobic or resistive exercise 2x/week or more
- Taking duloxetine, antipsychotics, benzodiazepines, or opioid analgesics
- Pregnant or lactating women
Where in United States
- University of Maryland School of MedicineBaltimore, United States
About the trial
What the trial wants to find out
This study evaluates the addition of duloxetine to aerobic exercise in the treatment of symptomatic knee osteoarthritis and depressive symptoms in adults. All participants will receive the receive the treatment protocol, which will first be evaluated in terms of feasibility and then pilot tested.
The group in the trial
- Aerobic exercise plus DuloxetineTreatment being tested
Participants will have a starting duloxetine dosage of 30 mg/day and be titrated up to a daily optimal dosage of 60 mg/day as tolerated during the first 12-weeks of the study. Twelve weeks after the receipt of their prescription, participants will be evaluated for the need to increase medication dosage to 90 mg/day. After duloxetine initiation, participants will be provided an exercise prescription that includes a progressive walking program aiming to achieve 50 minutes of moderate-intensity physical activity, three times per week, over 24 weeks.
Treatment: Aerobic exercise and Duloxetine
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Feasibility and Pilot Study of Combined Treatment Protocol Using Aerobic Exercise and Duloxetine in Older Adults With Symptomatic Knee Osteoarthritis and Comorbid Depression
- Publications
- Pilot study of duloxetine plus aerobic exercise for pain and depressive symptoms in knee osteoarthritis.Rheumatology advances in practice, 2026
- Duloxetine plus exercise for knee osteoarthritis and depression: A feasibility study.Osteoarthritis and cartilage open, 2024
- Record updated
- 29 October 2026